We are excited to announce that we added Emory Healthcare to our federated data network! 👏 Learn more: bwnews.pr/3TawTfK #HealthTech #AI #ClinicalTrials #MedicalAffairs #LifecycleManagement #healthcaredata #AI #FederatedAI #RWE #data

Part 3 of Pramana and Corista's Webinar is next week on Dec. 13 at 1pm ET! Register now to join industry experts for a discussion on the evolving role of #DICOM in enhancing diagnostic accuracy and efficiency. info.corista.com/dicom-webinar-…

We were featured on the Slice of Healthcare podcast about the power of our federated data network! Learn how we are using multimodal data to make significant strides in life sciences. bit.ly/3t0gjEH

Join us tomorrow for Part 3 of Pramana and Corista's Webinar on the Pros and Cons of DICOM for Digital Pathology! Join industry experts at 1PM ET for insightful discourse on the evolving role of #DICOM in enhancing diagnostic accuracy and efficiency. info.corista.com/dicom-webinar-…

What is the final barrier to the digital pathology revolution? Pramana Medical Director Asa Rubin tackles this question in The Pathologist, explaining how to overcome obstacles, foster community, and pave the way for the future of digital pathology. bit.ly/3uF6M6d

In case you missed it, Clinical Lab Products Magazine recently reshared a podcast episode with nference and Pramana Chief Product Officer Prasanth Perugupalli. Listen to the podcast: bit.ly/3Qaa9KP

How do federated data networks enhance R&D? By connecting diverse data sources, we can access #RWE insights from multiple institutions-fueling innovative drug development & evidence-based decisions. Learn how our #FederatedAI solves #realworldproblems nference.com/pharma

Unlock the profound world of healthcare insights with our #FederatedAI. Dive deep into patient progression, therapy indicators, and disease nuances. Discover the future of healthcare at nference.com

In case you missed it, the Duke Health #OneDukeGen initiative with nference to advance one of the largest clinical genomics sequencing and interpretation efforts was featured in Precision Medicine Online! 📰 lnkd.in/e3pPV8Su #FederatedAI

Embrace the future of healthcare with data-driven insights from nference's #FederatedAI. Transform patient care, predict outbreaks, personalize treatments, and more. Explore use cases at nference.com/nsights.

ICYMI: CAP TODAY shared a roundup of several of Pramana's exciting new collaborations with Caris Life Sciences, Intermountain Health, Gestalt Diagnostics, and Techcyte. Stay tuned for more exciting news in 2024! Read the article: captodayonline.com/newsbytes-1223…

Our federated data network provides access to de-identified patient data from top medical centers. nSights enables access as if it were on a single platform for a seamless experience. Learn more about how nSights can help you: nference.com/nsights

We're excited to speak at Precision Medicine World Conference next week in Silicon Valley! If you're at the event, make sure to attend VP of Scientific Research & Partnerships AJ Venkatakrishnan's talk on reimagining biomedicine in the age of AI. #FederatedAI #AI #DataAnalytics #healthcaredata #PMWC2024

If you're at Precision Medicine World Conference, come hear our VP of Scientific Research and Partnerships Dr. AJ Venkatakrishnan speak about reimagining biomedicine in the age of AI. #FederatedAI #RWE #AI #DataAnalytics #healthcaredata #PMWC2024

Through advances in data science, multimodal real-world data (#RWD) is becoming an essential tool for drug developers to identify the most appropriate patients to enroll in clinical trials. With our federated AI platform, #nSights, pharma leaders gain access to millions of

Anumana’s algorithms are #inthenews today! On the #TodayShow, Paul Friedman, MD, chair of Anumana's Scientific Advisory board explains how ECG-AI can detect #heartdisease earlier. Excited to work with the amazing team at #MayoClinic to supercharge ECGs and improve patient outcomes!

nference language models are able to identify disease warning signs earlier than health care professionals. With our Augmented Curation #AI technology, physicians and researchers can analyze disease signs and symptoms from unstructured clinical text at scale. AL amyloidosis is

Research led by nference and Madrigal Pharmaceuticals underscores the capacity of the Fibrosis-4 (FIB-4) index to forecast not only liver decompensation, but also cardiovascular events in patients with #NASH. The study highlights that a FIB-4 score as low as 1.0 can indicate significant

nference is honored to be recognized as one of the World’s Best #DigitalHealth Companies in 2024 by Newsweek. Request a demo of our #AI software platform that is transforming healthcare by making biomedical data computable: nference.com/demo newsweek.com/rankings/world…

nference was named one of the 50 best healthcare #DataAnalytics companies in the US, per Newsweek. Thank you to Becker's Hospital Review for highlighting the recognition: beckershospitalreview.com/digital-health… Request a demo of our AI software platform: nference.com/demo #RealWorldEvidence #AI